By blocking the TLR4 receptor, the extent of brain tissue edema, infarct size, and increased neurological damage scores after stroke are reduced in vivo, which possibly occurs via the TLR4/MyD88 signal pathway. The gene discussed is TLR4; the disease is stroke disorder.